Please Note: This trial is no longer enrolling new participants
A PHASE 1B, OPEN-LABEL STUDY OF ELRANATAMAB IN COMBINATION WITH IBERDOMIDE IN PARTICIPANTS WITH RELAPSED REFRACTORY MULTIPLE MYELOMA
Protocol No. | CTO-C1071030 | Scope | National |
---|---|---|---|
Principal Investigator | Attaya Suvannasankha | Treatment Type | Treatment |
Age Group | Adult | Phase | Phase I |